Posted On: 12/30/2013 3:15:20 AM
Post# of 72440
Mr.W, No problem. It's a statistical fact that given the same set of company fundamentals, most retail buyers will buy more often a company stock at $5.00+, then if it was $2.00. At $5.00 it's not a penny stock anymore, and your broker can sell it to you with it's now apparent inherent value since it's uplisted and is now on the radar and 'people are talking'.
But are you sure you will buy at $5.00?..many will say your buying into a 'spike' and the drop is 'right around the corner'. Then being unsure some may want to call Cramer and see what he thinks.
Here's what Bioman posted on Ihub:
>>
biomanbaba Thursday, 12/19/13 05:38:22 PM
Re: None
Post # of 49932
Shares under $2.00
Will be considered cheaper than dirt by the middle of next baseball season. Some think that is far off. Those without any
patience should hire full service brokers and play golf.
Those with patience will have money for NEW Pings and round at
St Andrews and treating the foursome at some fine Scottish establishment later that evening. CTIX will in my view be the
most talked about company at ASCO 2014. The catalyst news cycle
rules biotech stock performance and that continues. Stay tuned
I remain
T H E Biomanbaba
<<
So we waited this long, I believe we shall see soon. Good luck in all your trades.
-bunny-
But are you sure you will buy at $5.00?..many will say your buying into a 'spike' and the drop is 'right around the corner'. Then being unsure some may want to call Cramer and see what he thinks.
Here's what Bioman posted on Ihub:
>>
biomanbaba Thursday, 12/19/13 05:38:22 PM
Re: None
Post # of 49932
Shares under $2.00
Will be considered cheaper than dirt by the middle of next baseball season. Some think that is far off. Those without any
patience should hire full service brokers and play golf.
Those with patience will have money for NEW Pings and round at
St Andrews and treating the foursome at some fine Scottish establishment later that evening. CTIX will in my view be the
most talked about company at ASCO 2014. The catalyst news cycle
rules biotech stock performance and that continues. Stay tuned
I remain
T H E Biomanbaba
<<
So we waited this long, I believe we shall see soon. Good luck in all your trades.
-bunny-
(0)
(0)
Scroll down for more posts ▼